Clinical TrialsSearch results
Number of results: 738
Other
- An open label multi facilities cooperation randomized control trial to verify postprandial hyperglycemia and hypertriglyceridemia improving effects of DIMS therapy in type 2 diabetes. reducing effect of olmesartan therapy in diabetic nephropathy.
- Type-2 diabetic patient who has been being hospitalized in our facilities is bedridden and takes liquid diet.
- Graduate School of Medicine,Tohoku University
- 2009-03-01
Other
- The comparative study of the effects of miglitol and voglibose (alpha-glucosidase inhibitors) on incretins secretion
- type-2 diabetes
- Akita University School of Medicine Department of Endocrinology, Diabetes and Geriatric Medicine
- 2009-02-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Completed
- Luseogliflozin ABPM study
- Type 2 diabetes mellitus
- Cho Kyuyong
- 2019-03-19
Other
- Long-term effects of voglibose on diabetic complication in Japanese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled clinical trial
- Type 2 diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Study for the effects of imeglimin on glycemic control in patients with type 2 diabetes
- type 2 diabetes
- Nakamura Akinobu
- 2022-05-11
Other
- Study for the effects of semaglutid on glycemic control and quality of life in patients with type 2 diabetes
- type 2 diabetes
- Nomoto Hiroshi
- 2020-11-06